Sarah V. Williams

Oncogenic FGFR3 gene fusions in bladder cancer

Sarah V. Williams, Carolyn D. Hurst, Margaret A. Knowles · Human Molecular Genetics · 2012 · 380 citations · Full text

Medicine, Molecular Biology, Oncology +17

Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use

Harshnira Hitesh Patani, Tom D. Bunney, Nethaji Thiyagarajan et al. · Oncotarget · 2016 · 115 citations · Full text

Medicine, Molecular Biology, Oncology +17

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification

C D Hurst, Darren C. Tomlinson, Sarah V. Williams et al. · Oncogene · 2007 · 101 citations

Medicine, Molecular Biology, Oncology +8

The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study

Tom D. Bunney, Shunzhou Wan, Nethaji Thiyagarajan et al. · EBioMedicine · 2015 · 75 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +17

Chemokine receptor trafficking coordinates neutrophil clustering and dispersal at wounds in zebrafish

Caroline Coombs, Antonios Georgantzoglou, Hazel A. Walker et al. · Nature Communications · 2019 · 69 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17